Health Prescient Therapeutics targets $7 million raise to advance PTX-100 cancer program By Jonathan Jackson 25/08
Finance ASX SMIDcaps Conference to showcase small and mid-cap opportunities on September 23 By Jonathan Jackson 24/08
Health Recce Pharmaceuticals secures HREC approval for expanded Phase 3 diabetic foot infection trial By Jonathan Jackson 19/08
Health CSL shares surge 15% as investors look past loss to stronger FY27 outlook By Jonathan Jackson 18/08
Health OncoSil Medical secures US FDA approval for OncoSil device, opening A$80 million annual market By Jonathan Jackson 17/08
Health Pro Medicus lands A$23 million St Luke’s contract for cloud-based Visage 7 platform By Jonathan Jackson 12/08
Health Actinogen Medical to discuss future of Alzheimer’s treatment as pivotal XanaMIA readout approaches By Jonathan Jackson 12/08
Health Small Cap Watch: Actinogen hosts Alzheimer’s forum; SEG unveils MediaWorks deal and Pro Medicus wins US contract By Jonathan Jackson 12/08
Health Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway By Ephrem Joseph 12/08
Mining Small Cap Watch: S&P/ASX Small Ordinaries rises 0.62% as resources and healthcare stocks deliver updates By Jonathan Jackson 11/08
Mining Small Cap Watch: Dalaroo, D3 Energy, Pilbara Gold and Lindian advance projects By Jonathan Jackson 10/08
Health Percheron Therapeutics appoints Michael Baker as CEO as HMBD-002 trial approaches By Ephrem Joseph 10/08
Health The Small Cap Watch: Healthcare, critical minerals and gold explorers advance projects By Jonathan Jackson 06/08
Health Actinogen Medical outlines scientific case for Xanamem in Alzheimer’s disease ahead of pivotal trial results By Ephrem Joseph 06/08
